A Study of TQB2930 for Injection Monotherapy or Combination Chemotherapy in Patients With Recurrent/Metastatic Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Recurrent Breast Cancer
Interventions: DRUG: TQB2930 for injection|DRUG: Docetaxel injection
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.